Real FDA warning letters, and the Part 225 and Part 507 controls that prevent the same failures.
Medicated feed can fail in ways an animal owner never sees: the wrong drug in the mixer, too much drug in a batch, or residue left behind that reaches the next species. This course uses recent FDA warning letters to show how those failures happen in feed mills and what controls prevent them under 21 CFR Part 225 and the Part 507 preventive controls rule.
Learners begin with three real cases: a licensed mill that used monensin in place of a VFD drug, a mill with a lot containing more than three times the approved monensin level, and a mill with no flushing or sequencing between feeds. The course then covers drug identification and control in the mixing area, recording actual drug use by lot, and the daily comparison of actual and theoretical use under 225.42, with affected feed held until a discrepancy is resolved.
Next, learners compare the cleanout options in 225.65 (cleaning, flushing, sequencing, or an equally effective method), apply them across mixers, conveyors, bins and delivery trucks, and see why procedures and records matter. The course also shows how drug carryover, incorrect ingredients and mycotoxins belong in a Part 507 hazard analysis and food safety plan, with a qualified individual and validated controls.
Finally, learners cover invoices and weigh tickets that serve as labeling, VFD terms that must be followed, and how to answer an FDA warning letter within 15 working days with supporting records.
Medicated feed can fail in ways an animal owner never sees: the wrong drug in the mixer, too much drug in a batch, or residue that reaches the next species.
Completion certificate, PDF slide download, and access to the complete GMP course library from day one.
Start this course →